Rockwell Medical (RMTI) Cash from Financing Activities (2010 - 2026)

Rockwell Medical has reported Cash from Financing Activities for 17 years, with the latest figure at -$813000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 3.83% year-over-year to -$813000.0; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (down 33.9% YoY), and the FY2025 full-year result was $4.3 million, down 42.13% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$813000.0, up from -$1.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $26.8 million in Q2 2022, with the low at -$6.0 million in Q4 2022.
• Historically, Cash from Financing Activities has averaged $2.3 million across 5 years, with a median of -$631000.0 in 2023.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 447150.0% — and 2025, when it sank 539.89%.
• Rockwell Medical's Cash from Financing Activities stood at -$6.0 million in 2022, then surged by 87.6% to -$742000.0 in 2023, then jumped by 476.28% to $2.8 million in 2024, then tumbled by 137.93% to -$1.1 million in 2025, then gained by 23.23% to -$813000.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$813000.0 (Q1 2026), -$1.1 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.